Primary information |
---|
ID | antitb_1498 |
Peptide Name | Nisin A |
Sequence | not available |
N-terminal Modification | NA |
C-terminal Modification | NA |
Chemical Modification | NA |
Linear/ Cyclic | Branched cyclic |
Length | 0 |
Chirality | D |
Nature | Cationic |
Source | Natural |
Origin | Derived from Lactococcuslactis |
Species | Mycobacterium tuberculosis |
Strain | Mycobacteria kansasii CIT11/06 |
Inhibition Concentartion | IC90= 60 mg/ml (±0.13) |
In vitro/In vivo | in vitro |
Cell Line | NA |
Inhibition Concentartion | NA |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Response | NA |
Mechanism of Action | Inhibit biosynthesis of peptidoglycan and form pores in bacterial membrane |
Target | NA |
Combination Therapy | NA |
Other Activities | NA |
Pubmed ID | 25681127 |
Year of Publication | 2015 |
3-D Structure | NA |